Focus and Coverage
The Journal of Pharmacology and Pharmacotherapeutics (JPP) is an open access, peer reviewed journal which publishes high-quality articles pertaining to basic research and clinical studies in the domains of Pharmacology and Pharmacotherapeutics. Articles are freely accessible online in perpetuity under a Creative Commons License.

Contents from Current Issue
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. Background/PurposeComplications associated with diabetes are predominantly influenced by the polyol pathway, in which aldose reductase 2 (ALR2) is instrumental in converting surplus glucose into sorbitol, resulting in oxidative stress and cellular injury. …Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundImproving patient safety is vital, with medication errors posing serious risks. Understanding health professional students’ views on errors is crucial for fostering vigilant patient safety practices among future healthcare providers.PurposeThis …Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundUbrogepant is a successful drug used for the therapy of migraine. Purpose: The objective of this work was to formulate a novel nanoparticle-based therapy using ubrogepant for optimum therapeutic efficacy by quick and sustained action.MethodsThe …Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundThe Indian healthcare system faces significant challenges, such as data fragmentation, lack of interoperability, and concerns about data security. The increasing digitization of healthcare requires a robust infrastructure to address issues like …Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundCompetency-based medical education (CBME) is an approach that ensures that the focus of teaching, learning, and assessment is on real-life medical practice. There is a radical shift in the teaching, learning, and assessment methods from the …Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundPulmonary arterial hypertension is controlled by the dual endothelin receptor antagonist bosentan monohydrate. Recent advances in microneedle technology offer controlled, prolonged drug release.PurposeThis study formulated and evaluated a …Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundIn this modern era, the practice of online learning and various academic assignments necessitate the use of digital device among university students. With prolonged and inappropriate use, they are prone to the risk of experiencing digital eye …Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundChronic kidney disease (CKD) is a condition that deteriorates over time and causes the loss of nephrons, leading to impaired kidney function and finally bringing on end-stage renal disease (ESRD). As the world’s 12th biggest cause of mortality, …Read Original Source